Product Images Lyrica

View Photos of Packaging, Labels & Appearance

image description - New Doc 2017 02 02 (1)
Cockcroft and Gault equation - lyrica 01
Chemical Structure - lyrica 02
Figure 1 - lyrica 03
Figure 2 - lyrica 04
Figure 3 - lyrica 05
Figure 4 - lyrica 06
Figure 5 - lyrica 07
Figure 6 - lyrica 08
Figure 7 - lyrica 09
Figure 8 - lyrica 10
Figure 9 - lyrica 11
Figure 10 - lyrica 12
Figure 11 - lyrica 13
Logo - lyrica 14

Product Label Images

The following 15 images provide visual information about the product associated with Lyrica NDC 55700-488 by Lake Erie Medical Dba Quality Care Products Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - New Doc 2017 02 02 (1)

Cockcroft and Gault equation - lyrica 01

Chemical Structure - lyrica 02

Figure 1 - lyrica 03

Figure 2 - lyrica 04

The text appears to be a table showing the percentage improvement in pain for patients taking Pregabalin 160 mg over the course of three days. There are numbers listed under the headings "Percent of Patients Improved" and "Percent Improvement in Pain from Baseline." The remaining text is not clear or relevant enough to form a useful description.*

Figure 3 - lyrica 05

This is a report presenting information on the percent of patients who showed improvement in pain after taking different doses of Pregatalin and Pregabain. However, the formatting and quality make the text unclear and difficult to decipher.*

Figure 4 - lyrica 06

Figure 5 - lyrica 07

This document appears to be a clinical study comparing the effectiveness of Fregabalin and Pregataiin to a placebo in treating pain. The dosages used were Fregabalin 100mg three times a day and Pregataiin 80mg three times a day. The results are shown as a chart indicating the percentage of patients who experienced improvement. The chart shows a range from 0.8 to 88.8 percent improvement, and the percentage improvement in pain from the baseline is also provided.*

Figure 6 - lyrica 08

Figure 7 - lyrica 09

Figure 8 - lyrica 10

This seems to be a table displaying different doses of Pregabalin and a placebo, along with the percentage of improvement in pain from baseline for each one. The doses range from 10mg to 450mg daily. The table also shows that Pregabalin at a dose of 450mg per day has been approved.*

Figure 9 - lyrica 11

The text seems to be a table showing the estimated percentage of subjects without LTR for two different treatments (Pregabain and Placebo) at different time points (2 days and 12 days). Not enough context is provided to determine what LTR stands for, and the quality is not high enough to discern the other details.*

Figure 10 - lyrica 12

Figure 11 - lyrica 13

The given text seems to be a graph displaying the percentage of subjects improved over time (up to week 16) for two different treatments: Pregabalin and Placebo. The y-axis shows the percentage improved, ranging from 0 to 100, while the x-axis shows the range of values from 210 to 280. The graph shows that both treatments resulted in improvement, but Pregabalin appeared to have a higher percentage of improvement compared to Placebo.*

Logo - lyrica 14

This text indicates that a product or products are distributed by Parke-Davis, which is a division of Pfizer Inc. The address given is in New York, NY.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents